Bavdegalutamide (ARV110; ARV-110) is an orally bioavailable PROTAC-based Androgen Receptor (AR) degrader with potential anticancer activity. May be used for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

纯度：≥98%

CAS：2222112-77-6